Lockheed Martin just landed one of the largest single contract awards in company history. On July 29, the Department of War handed the defense giant a seven-year, up to $53.86 billion undefinitized contract action for PAC-3 Missile Segment Enhancement interceptors — pushing the total multiyear deal to $58.62 billion once a prior $4.7 billion award from April is factored in. The scale of the order reflects a stark supply gap: fewer than 800 Patriot missiles reportedly remain in U.S. inventories, with a CSIS report estimating the stockpile lost 65% of its prewar count during the recent Iran conflict.
Lockheed is responding by tripling PAC-3 MSE production capacity by the end of 2030 and growing its Camden, Arkansas workforce from 1,200 to roughly 1,850 employees, backed by $8-9 billion in facility investment through 2030. This marks Lockheed’s second major multiyear award under the Pentagon’s Acquisition Transformation Strategy, following a $35 billion THAAD contract earlier this year. The company generated $75.1 billion in FY2025 revenue, up 5.7%, with $6.9 billion in free cash flow. Hedge fund ownership climbed from 59 funds to 83 last quarter, while short interest sits at a thin 1.62% of float — signs of rising institutional conviction. Yet the stock’s forward P/E of 19.84 remains an ordinary multiple given the fresh backlog, suggesting the market hasn’t fully priced in the order flow.
Investors should weigh the bull case against real concentration risk. Roughly 72% of Lockheed’s 2025 sales came from the U.S. government, and the F-35 program alone makes up about 27% of revenue — a level of dependency that magnifies any shift in Washington’s spending priorities. Debt to equity sits near 3.2x, thinner than investors might expect for a company this size. Still, with a seven-year contract locked in, a depleted global stockpile, and officials describing wartime urgency around production, Lockheed offers a defense-sector name backed by concrete, multiyear revenue visibility — a rare combination in a market still guessing at AI valuations.
